Synergistic cytotoxicity of acidity and glucose degradation products in peritoneal dialysis fluid

Journal of Artificial Organs

Volumn 7, Issue 3, 2004, Pages 155-160

  Okabe, Eiji ^a   Tomo, Tadashi ^a   Tezono, Kazuhito ^a   Kikuchi, Hiroshi ^a   Kadota, Jyun Ichi ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acidity; Glucose degradation products (GDP); Human peritoneal mesothelial cells (HPMC); Peritoneal dialysis fluid (PDF); Synergistic cytotoxicity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 DEOXYGLUCOSONE; BUFFER; GLUCOSE DEGRADATION PRODUCT; GLYOXAL; HYDROCHLORIC ACID; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID; PHOSPHATE;

ACIDITY; ANALYTIC METHOD; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIALYSATE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM CELL; PH; PRIORITY JOURNAL;

CELL SURVIVAL; CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; HEAT; HYDROGEN-ION CONCENTRATION; PERITONEAL DIALYSIS; PERITONEUM; TETRAZOLIUM SALTS; THIAZOLES;

EID: 11244255224     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-004-0263-y     Document Type: Article

References (19)

1. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739
2. Di Paolo N, Garosi G, Traversari L, Di Paolo M. Mesothelial biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993;13 Suppl 2:8109-112
3. Breborowicz A, Rodela H, Karon J, Martis L, Oreopoulos DG. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells. Am J Kidney Dis 1997;29:404-409
4. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001;12:2434-2441
5. Lage C, Pischetsrieder M, Aufricht C, Jorres A, Schilling H, Passlick-Deetjen J. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000;20 Suppl 5:S28-32
6. Topley N, Kaur D, Petersen MM, Jorres A, Passlick-Deetjen J, Coles GA, Williams DJ. Biocompatibility of bicarbonate-buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996;49:1447-1456
7. Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995;47:282-293
8. De Vriese AS, Mortier S, Lameire NH. What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 2001;21 Suppl 3:89-18
9. Wieczorowska-Tobis K, Polubinska A, Schaub TP, Schilling H, Wisniewska J, Witowski J, Passlick-Deetjen J, Breborowicz A. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Perit Dial Int 2001;21 Suppl 3:8108-113
10. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, Watanabe H, Takahashi N. Influence of pH-neutral peritoneal dialysis solution. Adv Perit Dial 2002;18:68-71
11. Musi B, Carlsson O, Rippe A, Wieslander A, Rippe B. Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit Dial Int 1998;18:303-310
12. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den Born J, Beelen RJ. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 2003;23:213-221
13. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002;62:697-703
14. Linden T, Forsback G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998;18:290-293
15. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-1570
16. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987;47:936-942
17. Miyata T, Horie K, Ueda Y, Fujita Y, Izuhara Y, Hirano H, Uchida K, Saito A, Van Ypersele De Strihou C. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000;58:425-435
18. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999;19:325-333
19. Wieslander A, Linden T, Kjellstrand P. Glucose degradation products in peritoneal dialysis fluids: how they can be avoided. Perit Dial Int 2001;21 Suppl 3:S119-124